“An Analysis of the Benefits of SGLT2 Inhibitors in the Progression of Chronic Kidney Disease Beyond Type 2 Diabetes”. 2024. Revista Eletrônica Acervo Médico 24 (August): e16309. https://doi.org/10.25248/reamed.e16309.2024.